SCHEMBL3157124

SCHEMBL3157124

[CH2]COCc1ccccc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.46
TAAR1 Q96RJ0 1/20 0.43
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
CDK4 P11802 2/20 0.40
CCND1 P24385 2/20 0.40
CYP2A13 Q16696 1/20 0.39
ACHE P22303 2/20 0.38
TSHR P16473 1/20 0.38
CHRM2 P08172 1/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
CHRM3 P20309 1/20 0.37
KMT2A Q03164 2/20 0.36
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4315585 0.86 TAAR1 (0.50) MAOBTAAR1ADRA2AADRA2BADRA2C
SCHEMBL2712926 0.81 TAAR1 (0.50) MAOBTAAR1ADRA2AADRA2BADRA2C
SCHEMBL2097131 0.80 CHRM3 (0.39) MAOBTAAR1ADRA2AADRA2BADRA2C
SCHEMBL8750455 0.80 TAAR1 (0.45) MAOBTAAR1ADRA2AADRA2BADRA2C
SCHEMBL23343755 0.78 MAOB (0.46) MAOBTAAR1ADRA2AADRA2BADRA2C
SCHEMBL10814076 0.78 TAAR1 (0.43) MAOBTAAR1ADRA2AADRA2BADRA2C
Ethylene Glycol SCHEMBL7751137 0.78 MAOB (0.46) MAOBTAAR1ADRA2AADRA2BADRA2C
SCHEMBL7193095 0.78 TAAR1 (0.43) MAOBTAAR1ADRA2AADRA2BADRA2C
Ammonia Solution, Strong SCHEMBL21518160 0.78 TAAR1 (0.43) MAOBTAAR1ADRA2AADRA2BADRA2C
Hydroquinone SCHEMBL10865260 0.78 MAOB (0.46) MAOBTAAR1ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111315828-B Composition, cured product, optical filter, and method for producing cured product 株式会社艾迪科 2023-09-29 CN disclosed
CN-112154167-B Composition, cured product, optical filter, and method for producing cured product 株式会社艾迪科 2023-08-22 CN disclosed
CN-107918247-B Colored curable resin composition 住友化学株式会社 2022-03-18 CN disclosed
CN-106019840-B Colored curable resin composition 东友精细化工有限公司 2021-01-29 CN disclosed
CN-112154167-A Composition, cured product, optical filter, and method for producing cured product 株式会社艾迪科 2020-12-29 CN disclosed
CN-111315828-A Composition, cured product, optical filter, and method for producing cured product 株式会社艾迪科 2020-06-19 CN disclosed
CN-104298073-B Colored curable resin composition 东友精细化工有限公司 2019-11-29 CN disclosed
CN-107001299-A Compound and colored curable resin composition 东友精细化工有限公司 2017-08-01 CN disclosed
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-01 US disclosed
EP-2061789-A2 THIADIAZOLE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2009-05-27 EP disclosed
WO-2008032858-A2 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF NR2C2, NR4A3, NR0B2 MAOB 1907/4885TAAR1 70/4885ADRA2A 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.